ECPI Global ESG Agri-Business

Derived from the STOXX Global ESG Leaders index, the STOXX Europe ESG Leader 50 index covers the 50 largest stocks from 17 European countries: Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom. The index is designed to serve as a highly liquid underlying for financial products.

The STOXX Global ESG Leaders index provides access to the leading global companies in terms of environmental, social and governance criteria, using a bottom-up selection approach based on ESG Risk Ratings provided by Sustainalytics. Companies that are non-compliant based on the Sustainalytics’ Global Standards Screening assessment or are involved in controversial weapons are not eligible for selection. Additional exclusion filters are applied, screening companies for involvement in tobacco production and distribution, thermal coal extraction and power generation, small arms manufacturing, military contracting, unconventional oil and gas exploration and production, and ESG Controversies.

Index Guides, Benchmark statement, and other reports are available under the Data tab.

Note: Dissemination of the index is suspended.

The iSTOXX Global ESG Eurozone Leg Equal Weight Index aims to replicate an investment in the 60 largest stocks by free-float market capitalization from the EURO STOXX ESG-X Index where companies are eligible if they are not involved in Unconventional Oil & Gas and if they are in the top 120 in terms of ESG, as calculated by Sustainalytics. The constituents are equal-weighted and the index is reviewed on a quarterly basis.

Index Guides, Benchmark statement, and other reports are available under the Data tab.

The ECPI Global ESG Silver Economy Index is designed to offer investors exposure to listed companies in global developed markets characterized by a positive ESG profile and that are the ones best placed to grasp the benefits deriving from life expectancy increase and aging population, pharmaceutical and medical innovation, changes in lifestyle and spending capacity of elderly cohorts of population.

Index Guides, Benchmark statement, and other reports are available under the Data tab.